Silver Kristopher, Littlejohn Alaina, Thomas Laurel, Marsh Elizabeth, Lillich James D
Department of Anatomy and Physiology, Kansas State University, Manhattan, KS 66506, United States.
Department of Anatomy and Physiology, Kansas State University, Manhattan, KS 66506, United States.
Biochem Pharmacol. 2015 Dec 15;98(4):614-28. doi: 10.1016/j.bcp.2015.10.017. Epub 2015 Nov 7.
Clinical use of non-steroidal anti-inflammatory drugs (NSAIDs) is well known to cause gastrointestinal ulcer formation via several mechanisms that include inhibiting epithelial cell migration and mucosal restitution. The drug-affected signaling pathways that contribute to inhibition of migration by NSAIDs are poorly understood, though previous studies have shown that NSAIDs depolarize membrane potential and suppress expression of calpain proteases and voltage-gated potassium (Kv) channel subunits. Kv channels play significant roles in cell migration and are targets of NSAID activity in white blood cells, but the specific functional effects of NSAID-induced changes in Kv channel expression, particularly on cell migration, are unknown in intestinal epithelial cells. Accordingly, we investigated the effects of NSAIDs on expression of Kv1.3, 1.4, and 1.6 in vitro and/or in vivo and evaluated the functional significance of loss of Kv subunit expression. Indomethacin or NS-398 reduced total and plasma membrane protein expression of Kv1.3 in cultured intestinal epithelial cells (IEC-6). Additionally, depolarization of membrane potential with margatoxin (MgTx), 40mM K(+), or silencing of Kv channel expression with siRNA significantly reduced IEC-6 cell migration and disrupted calpain activity. Furthermore, in rat small intestinal epithelia, indomethacin and NS-398 had significant, yet distinct, effects on gene and protein expression of Kv1.3, 1.4, or 1.6, suggesting that these may be clinically relevant targets. Our results show that inhibition of epithelial cell migration by NSAIDs is associated with decreased expression of Kv channel subunits, and provide a mechanism through which NSAIDs inhibit cell migration and may contribute to NSAID-induced gastrointestinal (GI) toxicity.
众所周知,非甾体抗炎药(NSAIDs)的临床使用会通过多种机制导致胃肠道溃疡形成,这些机制包括抑制上皮细胞迁移和黏膜修复。尽管先前的研究表明NSAIDs会使膜电位去极化,并抑制钙蛋白酶和电压门控钾(Kv)通道亚基的表达,但对NSAIDs抑制迁移所涉及的药物影响信号通路仍知之甚少。Kv通道在细胞迁移中起重要作用,并且是NSAIDs在白细胞中的活性靶点,但NSAIDs诱导的Kv通道表达变化对细胞迁移的具体功能影响,在肠上皮细胞中尚不清楚。因此,我们研究了NSAIDs在体外和/或体内对Kv1.3、1.4和1.6表达的影响,并评估了Kv亚基表达缺失的功能意义。吲哚美辛或NS-398降低了培养的肠上皮细胞(IEC-6)中Kv1.3的总蛋白和质膜蛋白表达。此外,用玛格毒素(MgTx)、40mM K(+)使膜电位去极化,或用小干扰RNA(siRNA)沉默Kv通道表达,均显著降低IEC-6细胞迁移并破坏钙蛋白酶活性。此外,在大鼠小肠上皮中,吲哚美辛和NS-398对Kv1.3、1.4或1.6的基因和蛋白表达有显著但不同的影响,表明这些可能是临床相关靶点。我们的结果表明,NSAIDs对上皮细胞迁移的抑制与Kv通道亚基表达降低有关,并提供了一种NSAIDs抑制细胞迁移的机制,这可能导致NSAIDs诱导的胃肠道(GI)毒性。